N/A
N=119
DrIFT 2 Study: Displacement in Feeding Tubes
Enteral Nutrition
Bottom Line
View on ClinicalTrials.gov: NCT06239610 ↗Enrolled (actual)
119
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcome: Primary: Tube Migration — 6 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- electromagnetic placement device (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Parkview Health
- Primary completion
- Aug 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Tube Migration |
6 | — |
| PRIMARY Effect of ETT Extubation on FT Movement |
2 | — |
Summary
The proposed study will use an electromagnetic placement device (EMPD), Cortrak* 2 Enteral Access System (EAS™), Avanos Medical, to verify feeding tube (FT) position on a daily basis to assess for migration. The EMPD provides real-time FT placement data. A sensor located on the distal end of the FT guidewire communicates with a receiver unit which sits on the patient's abdomen. Three visual insertion tracings with varying views (anterior, lateral, and depth/cross-section) can be saved and printed for comparison.
Eligibility Criteria
Inclusion Criteria
- Adult critical care patients with small bore feeding tube inserted within last 24-48 hours
- Initial Cortrak insertion tracings: all 3 views available
- Cortrak guidewire available
Exclusion Criteria
- Unable to speak or understand English language
- Pregnancy
- Prisoners
- FT anticipated to be removed within 24 hours
- Contraindications to placing a mark on the abdomen for top foot of receiver unit (large dressings, open abdomen, halo vest, etc.)
- Original guidewire unavailable
Data sourced from ClinicalTrials.gov (NCT06239610). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.